These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2685709)

  • 21. Reasons for and management of postvitrectomy vitreous hemorrhage in proliferative diabetic retinopathy.
    Yan H; Cui J; Lu Y; Yu J; Chen S; Xu Y
    Curr Eye Res; 2010 Apr; 35(4):308-13. PubMed ID: 20373898
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early vitrectomy for severe vitreous hemorrhage in diabetic retinopathy. Four-year results of a randomized trial: Diabetic Retinopathy Vitrectomy Study Report 5.
    Arch Ophthalmol; 1990 Jul; 108(7):958-64. PubMed ID: 2196036
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Healon GV in posterior segment surgery.
    Crafoord S; Stenkula S
    Acta Ophthalmol (Copenh); 1993 Aug; 71(4):560-1. PubMed ID: 8249593
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Intraocular pressure during vitrectomy in diabetic patients].
    Chagnon A; Payan J; Levy C; Chassain C
    Bull Soc Ophtalmol Fr; 1989 Mar; 89(3):443-8. PubMed ID: 2598392
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Vitrectomy via pars plana. A histological study and an analysis of clinical results (author's transl)].
    Gnad HD
    Wien Klin Wochenschr Suppl; 1980; 108():1-22. PubMed ID: 6769257
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Postoperative pressures after phacoemulsification: sodium hyaluronate vs. sodium chondroitin sulfate-sodium hyaluronate.
    Embriano PJ
    Ann Ophthalmol; 1989 Mar; 21(3):85-8, 90. PubMed ID: 2500055
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravitreal triamcinolone acetonide injection at the end of vitrectomy for diabetic vitreous hemorrhage: a randomized, clinical trial.
    Faghihi H; Taheri A; Farahvash MS; Esfahani MR; Rajabi MT
    Retina; 2008 Oct; 28(9):1241-6. PubMed ID: 18626423
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peripheral retinal cryotherapy for postvitrectomy diabetic vitreous hemorrhage in phakic patients.
    Cekic O; Batman C
    Am J Ophthalmol; 1999 Jun; 127(6):740-1. PubMed ID: 10372896
    [No Abstract]   [Full Text] [Related]  

  • 29. [Vitrectomy in proliferative diabetic retinopathy. Preoperative factors for surgical procedure and postoperative results].
    Ulbig M; Kampik A; Heidenkummer HP
    Fortschr Ophthalmol; 1990; 87(5):443-8. PubMed ID: 2272571
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictive clinical features and outcomes of vitrectomy for proliferative diabetic retinopathy.
    Yorston D; Wickham L; Benson S; Bunce C; Sheard R; Charteris D
    Br J Ophthalmol; 2008 Mar; 92(3):365-8. PubMed ID: 18303158
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endophthalmitis in eyes following vitrectomy.
    Sharma T; Gopal L; Therese L
    Ophthalmic Surg Lasers; 1998 Oct; 29(10):857-9. PubMed ID: 9793954
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Different outcome among eyes with proliferative diabetic retinopathy indicated for vitrectomy].
    Muramatsu M; Yokoi M; Muramatsu A; Saito W; Furudate N; Ohno S
    Nippon Ganka Gakkai Zasshi; 2006 Dec; 110(12):950-60. PubMed ID: 17228758
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intravitreal bevacizumab for prevention of early postvitrectomy hemorrhage in diabetic patients: a randomized clinical trial.
    Ahmadieh H; Shoeibi N; Entezari M; Monshizadeh R
    Ophthalmology; 2009 Oct; 116(10):1943-8. PubMed ID: 19699531
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of Tamponade in Vitrectomy for Proliferative Diabetic Retinopathy with Vitreous Hemorrhage.
    Balakrishnan D; Jain B; Nayaka A; Rani PK; Mukundaprasad V; Jalali S
    Semin Ophthalmol; 2017; 32(4):488-491. PubMed ID: 27128601
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fibrovascular ingrowth and recurrent haemorrhage following diabetic vitrectomy.
    West JF; Gregor ZJ
    Br J Ophthalmol; 2000 Aug; 84(8):822-5. PubMed ID: 10906084
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of intravitreal bevacizumab as a pretreatment of vitrectomy for diabetic vitreous hemorrhage on recurrent hemorrhage.
    Berk Ergun S; Toklu Y; Cakmak HB; Raza S; Simsek S
    Semin Ophthalmol; 2015 May; 30(3):177-80. PubMed ID: 24409948
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Entry site neovascularization and vitreous cavity hemorrhage after diabetic vitrectomy. The predictive value of inner sclerostomy site ultrasonography.
    Steel DH; Habib MS; Park S; Hildreth AJ; Owen RI
    Ophthalmology; 2008 Mar; 115(3):525-32. PubMed ID: 17976729
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early postoperative intraocular pressure stability after combined 23-gauge sutureless vitrectomy and cataract surgery in patients with proliferative diabetic retinopathy.
    Lee JY; Jeong HS; Lee DY; Sohn HJ; Nam DH
    Retina; 2012 Oct; 32(9):1767-74. PubMed ID: 22481480
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of the effects of Viscoat and Healon on postoperative intraocular pressure.
    Barron BA; Busin M; Page C; Bergsma DR; Kaufman HE
    Am J Ophthalmol; 1985 Sep; 100(3):377-84. PubMed ID: 4037023
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Extracapsular cataract extraction and implantation in the capsular sac during vitrectomy in diabetics].
    Pagot V; Gazagne C; Galiana A; Giraud MA; Malecaze F; Mathis A
    J Fr Ophtalmol; 1991; 14(10):523-8. PubMed ID: 1791275
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.